Literature DB >> 8707880

Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.

F Van Ruissen1, G J de Jongh, P L Zeeuwen, P E Van Erp, P Madsen, J Schalkwijk.   

Abstract

Lesional psoriatic epidermis displays a number of phenotypic changes that are distinct from the differentiation program found in normal interfollicular epidermis. In psoriatic epidermis, keratinocytes are hyperproliferative and several differentiation-associated molecules are expressed that are absent in normal skin (e.g., cytokeratins (CK) 6, 16, and 17, and the epidermal proteinase inhibitor SKALP/ elafin). In addition, several molecules which are normally restricted to the stratum granulosum are strongly upregulated in the stratum spinosum (e.g., psoriasis-associated fatty acid binding protein (PA-FABP), psoriasin, involucrin, and transglutaminase). The aim of this study was to develop in vitro culture systems which (a) would allow to study the induction of normal and psoriatic differentiation pathways, and (b) would be amenable for screening of antipsoriatic drugs. Here we have investigated several models for induction of differentiation with respect to the expression of markers for the normal and psoriatic phenotype. Cell cycle parameters and expression levels of CK1, CK10, CK16, SKALP/elafin, transglutaminase, involucrin, psoriasin, and PA-FABP were assessed in these models using flow cytometry, immunocytochemistry, and Northern blot analysis. We observed that induction of differentiation with fetal calf serum resembled the psoriatic phenotype (sustained hyperproliferation; high levels of CK16, SKALP/elafin, transglutaminase, and involucrin; moderate psoriasin expression), whereas differentiation induced by growth factor depletion in a confluent culture resembled the normal differentiation phenotype (low proliferative rate; high expression levels of CK1 and CK10; moderate expression of involucrin and transglutaminase; low expression levels of SKALP/elafin and CK16; absence of psoriasin). We propose that these models can be used to study expression and pharmacological modulation of selected differentiation genes and the coordinated expression of sets of genes associated with epidermal differentiation programs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707880     DOI: 10.1002/(SICI)1097-4652(199608)168:2<442::AID-JCP23>3.0.CO;2-3

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

1.  Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay.

Authors:  Arno Pol; Mieke Bergers; Joost Schalkwijk
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

2.  Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.

Authors:  Sylviane Lambert; William R Swindell; Lam C Tsoi; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2017-03-06       Impact factor: 8.551

Review 3.  The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.

Authors:  J Schalkwijk; O Wiedow; S Hirose
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

4.  In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research.

Authors:  Eline Desmet; Anesh Ramadhas; Jo Lambert; Mireille Van Gele
Journal:  Exp Biol Med (Maywood)       Date:  2017-06

5.  Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction.

Authors:  Ellen H van den Bogaard; Diana Rodijk-Olthuis; Patrick A M Jansen; Ivonne M J J van Vlijmen-Willems; Piet E van Erp; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  Tissue Eng Part A       Date:  2012-06-05       Impact factor: 3.845

Review 6.  Psoriasis genetics: breaking the barrier.

Authors:  Elisha D O Roberson; Anne M Bowcock
Journal:  Trends Genet       Date:  2010-08-06       Impact factor: 11.639

7.  Psoriasin (S100A7) expression is altered during skin tumorigenesis.

Authors:  Salem Alowami; Gefei Qing; Ethan Emberley; Linda Snell; Peter H Watson
Journal:  BMC Dermatol       Date:  2003-02-24

8.  Development and validation of human psoriatic skin equivalents.

Authors:  Geuranne Tjabringa; Mieke Bergers; Desiree van Rens; Roelie de Boer; Evert Lamme; Joost Schalkwijk
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

9.  Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.

Authors:  R Pfundt; F van Ruissen; I M van Vlijmen-Willems; H A Alkemade; P L Zeeuwen; P H Jap; H Dijkman; J Fransen; H Croes; P E van Erp; J Schalkwijk
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.

Authors:  Ellen H van den Bogaard; Judith G M Bergboer; Mieke Vonk-Bergers; Ivonne M J J van Vlijmen-Willems; Stanleyson V Hato; Pieter G M van der Valk; Jens Michael Schröder; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.